[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,367,410
  • Shares Outstanding, K 231,458
  • Annual Sales, $ 2,348 M
  • Annual Income, $ 128,370 K
  • EBIT $ -31 M
  • EBITDA $ 26 M
  • 60-Month Beta 2.37
  • Price/Sales 2.71
  • Price/Cash Flow 32.87
  • Price/Book 14.23

Options Overview Details

View History
  • Implied Volatility 83.59% (-1.95%)
  • Historical Volatility 82.08%
  • IV Percentile 40%
  • IV Rank 35.70%
  • IV High 127.22% on 10/16/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 7) 2.35 (8.41%)
  • Put/Call Vol Ratio 0.22
  • Today's Volume 175,371
  • Volume Avg (30-Day) 152,073
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 1,071,623
  • Open Int (30-Day) 1,079,348
  • Expected Range 25.66 to 30.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.02
  • Number of Estimates 4
  • High Estimate $0.15
  • Low Estimate $-0.16
  • Prior Year $0.17
  • Growth Rate Est. (year over year) -111.76%

Price Performance

See More
Period Period Low Period High Performance
1-Month
21.53 +30.10%
on 05/19/26
30.39 -7.82%
on 05/11/26
+0.74 (+2.71%)
since 05/04/26
3-Month
15.21 +84.16%
on 03/06/26
31.85 -12.07%
on 04/20/26
+11.56 (+70.27%)
since 03/04/26
52-Week
13.74 +103.86%
on 02/24/26
70.43 -60.23%
on 07/31/25
-25.60 (-47.75%)
since 06/04/25

Most Recent Stories

More News
Hims & Hers Names Dr. Anant Vinjamoori as Chief Medical Officer of Hims

An expert in longevity medicine and preventive healthcare, Vinjamoori joins Hims & Hers to help more men feel great at every stage of life

HIMS : 28.01 (+1.82%)
1 Growth Stock Set to Flourishand 2 We Ignore

1 Growth Stock Set to Flourishand 2 We Ignore

ADSK : 233.64 (+1.76%)
HIMS : 28.01 (+1.82%)
PLUS : 80.90 (+0.63%)
Hims & Hers Completes Acquisition of Eucalyptus, Expanding Access to Comprehensive, Clinically-Backed Weight Management Care in Germany

Closing brings world-class technology and clinical infrastructure to a market where Juniper has helped patients achieve clinically meaningful weight loss

HIMS : 28.01 (+1.82%)
Hims & Hers Completes Acquisition of Eucalyptus, Advancing Position as the World's Largest Consumer Health Platform

Entering Australia for the first time, Hims & Hers will combine scale, technology, and clinical expertise to make personalised, whole-body care more accessible to every Australian

HIMS : 28.01 (+1.82%)
Hims & Hers Completes Acquisition of Eucalyptus, Parent Company of Juniper, Officially Entering Japanese Market

Closing brings the scale, technology and clinical infrastructure of Hims & Hers to Japan

HIMS : 28.01 (+1.82%)
Hims & Hers Completes Acquisition of Eucalyptus, Advancing its Position as the World’s Largest Consumer Health Platform

The acquisition extends the company's leadership position across Australia, Canada, Germany, Japan, and the United Kingdom, with the scale to redefine healthcare for hundreds of millions of people

HIMS : 28.01 (+1.82%)
Hims & Hers Completes Acquisition of Eucalyptus, Accelerating Its Push to Transform Healthcare for Canadians

Building on its Canadian launch and the historic introduction of generic semaglutide, Hims & Hers brings the full power of the world's largest consumer health platform — and Juniper's proven track record...

HIMS : 28.01 (+1.82%)
2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds

2 Unprofitable Stocks with Competitive Advantages and 1 Facing Headwinds

HIMS : 28.01 (+1.82%)
MTRX : 14.26 (+3.26%)
HASI : 40.24 (+0.27%)
Hims & Hers Expands Benefits for Active Subscribers With Eight New Health and Wellness Partners

From connected fitness and cycle tracking to meal delivery and glucose monitoring, Hims & Hers subscribers now have ten ways to support their whole-body health

HIMS : 28.01 (+1.82%)
Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

HIMS : 28.01 (+1.82%)
NVO : 43.75 (+4.17%)
LLY : 1,125.27 (+4.31%)
ABBV : 224.94 (+3.60%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 32.19
2nd Resistance Point 31.00
1st Resistance Point 29.51
Last Price 28.01
1st Support Level 26.83
2nd Support Level 25.64
3rd Support Level 24.15

See More

52-Week High 70.43
Fibonacci 61.8% 48.77
Fibonacci 50% 42.08
Fibonacci 38.2% 35.40
Last Price 28.01
52-Week Low 13.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.